Skip to main content

Table 2 Survival according to the lepidic component and type

From: The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung

  N 1 yr. (95 % CI) 2 yr. (95 % CI) 5 yr. (95 % CI) 10 yr. (95 % CI)
Total 101 84.2 (77.3-91.6) 76.2 (68.3-85.0) 58.1 (49.2-68.6) 34.1 (25.9-44.8)
Lepidic component      
<50 % 44 84.1 (73.9-95.6) 72.6 (60.5-87.1) 56.2 (43.2-73.1) 32.8 (21.4-50.3)
50-79 % 26 80.8 (67.0-97.4) 72.6 (60.5-87.1) 56.2 (43.2-73.1) 32.8 (21.4-50.3)
80-95 % 24 87.5 (75.2-100) 87.5 (75.2-100) 66.7 (50.2-88.5) 37.5 (22.4-62.9)
96-100 % 6 83.3 (58.3-100) 83.3 (58.3-100) 66.7 (37.9-100) 50.0 (22.5-100)
Unknown 1     
Lepidic type      
Mucinous 16 75.0 (56.5-99.5) 62.5 (42.8-91.4) 31.2 (15.1-64.6) 12.5 (3.4-45.7)
Non-mucinous 71 88.7 (81.7-96.4) 81.7 (73.2-91.2) 69.0 (59.1-80.7) 43.7 (33.5-56.9)
Mucinous and non-mucinous 14 71.4 (51.3-99.5) 63.5 (42.4-95.1) 31.8 (14.2-70.8) 7.9 (1.2-51.9)
  1. Yr. - Year, CI - Confidence interval